13 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
, human error, and fraud. Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
. Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted
S-1
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise
DRS/A
1s58vcq
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
ckk83fqtom9z 8q9t78
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
71o27m1k
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
xxd1fv bgvu
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
mpg0vg tn
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
8j1ktceo
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
zbcox99
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
77pjt lguyebirkb
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next